![Elisabeth Scholander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Elisabeth Scholander is currently the Vice President of Research & Development at Carmeda AB since 1991.
Prior to this, she worked as a Research Chemist at Medicarb AB.
Elisabeth Scholander active positions
Companies | Position | Start |
---|---|---|
Carmeda AB
![]() Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Chief Tech/Sci/R&D Officer | 1990-12-31 |
Former positions of Elisabeth Scholander
Companies | Position | End |
---|---|---|
Medicarb AB
![]() Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Carmeda AB
![]() Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Health Technology |
Medicarb AB
![]() Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Health Technology |
- Stock Market
- Insiders
- Elisabeth Scholander